Jessica Matthews

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes

Jessica Matthews, Murray Stewart, Erika H. De Boever et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 196 citations · Full text

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects

Mark Bush, Jessica Matthews, Erika H. De Boever et al. · Diabetes Obesity and Metabolism · 2009 · 177 citations

High-affinity neuropeptide Y receptor antagonists.

Alex J. Daniels, Jessica Matthews, Ruta Slepetis et al. · Proceedings of the National Academy of Sciences · 1995 · 139 citations · Full text

Neuropeptides, Sympathetic Nerve Terminals, Pharmacotherapy +18

Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies

Michael Aboud, Chloe Orkin, Daniel Podzamczer et al. · The Lancet HIV · 2019 · 110 citations

Treatment And Prevention, Antiviral Drug Development, Antiviral Therapy +9

Prevalence and Significance of Nonthromboembolic Findings on Chest Computed Tomography Angiography Performed to Rule Out Pulmonary Embolism: A Multicenter Study of 1,025 Emergency Department Patients

Peter B. Richman, D. Mark Courtney, J. Friese et al. · Academic Emergency Medicine · 2004 · 94 citations